Irinotecan, oxaliplatin, 5-fluorouracil/leucovorin (mFOLFIRINOX) as first-line therapy in advanced Her2-negative gastric or gastroesophageal adenocarcinoma (G/GEA) . ; Volume 29 (Supplement 8), October 2018, p-viii227, abstract 675Pтезисы доклада